Home
About
Overview
Sharing Data
ORCID
Help
History (3)
A randomised, double-blind, placebo-controlled study of the LAG-3-depleting monoclonal antibody GSK2831781 in patients with active ulcerative colitis.
C5a alters blood-brain barrier integrity in experimental lupus.
Principal Investigator
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
C5a alters blood-brain barrier integrity in experimental lupus.
C5a alters blood-brain barrier integrity in experimental lupus. FASEB J. 2010 Jun; 24(6):1682-8.
View in:
PubMed
subject areas
Animals
Blood-Brain Barrier
Blotting, Western
Brain
Cells, Cultured
Complement Activation
Complement C5a
Disease Models, Animal
Endothelium, Vascular
Lupus Erythematosus, Systemic
Mice
Mice, Inbred C57BL
Mice, Inbred MRL lpr
Nitric Oxide Synthase Type II
Reactive Oxygen Species
Receptor, Anaphylatoxin C5a
Reverse Transcriptase Polymerase Chain Reaction
RNA, Messenger
Signal Transduction
authors with profiles
Richard Quigg